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ABSTRACT  24 
 25 
Study question: Is serum vitamin D associated with live birth rates in women undergoing assisted 26 
reproductive treatment? 27 
 28 
Summary answer: Women undergoing assisted reproductive treatment who are replete in vitamin D 29 
have a higher live birth rate than women who are vitamin D deficient or insufficient. 30 
 31 
What is known already: Vitamin D deficiency has been associated with an increased risk of 32 
abnormal pregnancy implantation as well as obstetric complications such as pre-eclampsia and fetal 33 
growth restriction. However, the effect of vitamin D on conception and early pregnancy outcomes in 34 
couples undergoing assisted reproductive treatment is poorly understood. 35 
 36 
Study design, size, duration: A systematic review and meta-analysis of 11 published cohort studies 37 
(including 2700 women) investigating the association between vitamin D and assisted reproductive 38 
treatment outcomes. 39 
 40 
Participants/materials, settings, methods:  Literature searches were conducted to retrieve studies 41 
which reported on the association between vitamin D and assisted reproductive treatment 42 
outcomes. Databases searched included MEDLINE, EMBASE, Cochrane Central Register of Controlled 43 
Trials and CINAHL. Eleven studies matched the inclusion criteria. 44 
 45 
Main results and the role of chance: Live birth was reported in seven of the included studies 46 
(including 2026 patients). Live birth was found to be more likely in women replete in vitamin D when 47 
compared to women with deficient or insufficient vitamin D status (OR 1.33 [1.08 to 1.65]). Five 48 
studies (including 1700 patients) found that women replete in vitamin D were more likely to achieve 49 
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a positive pregnancy test than women deficient or insufficient in vitamin D (OR 1.34 ([1.04 to 1.73]). 50 
All 11 of the included studies (including 2700 patients) reported clinical pregnancy as an outcome. 51 
Clinical pregnancy was found to be more likely in women replete in vitamin D (OR 1.46[1.05 to 52 
2.02]). Six studies (including 1635 patients) reported miscarriage by vitamin D concentrations. There 53 
was no association found between miscarriage and vitamin D concentrations (OR 1.12 [0.81 to 1.54]. 54 
The included studies scored well on the Newcastle Ottawa quality assessment scale.  55 
 56 
Limitations, reasons for caution: Although strict inclusion criteria were used in the conduct of the 57 
systematic review, the included studies are heterogeneous in population characteristics and fertility 58 
treatment protocols. 59 
 60 
Wider implications of the findings: The findings of this systematic review show that there is an 61 
association between vitamin D status and reproductive treatment outcomes achieved in women 62 
undergoing assisted reproductive treatment. Our results show that vitamin D deficiency and 63 
insufficiency could be important conditions to treat in women considering assisted reproductive 64 
treatments. A randomised controlled trial to investigate the benefits of vitamin D deficiency 65 
treatment should be considered to test this hypothesis. 66 
 67 
Study funding/competing interests: No external funding was either sought or obtained for this 68 
study. The authors have no competing interests to declare.  69 
 70 
Registration number: N/A 71 
 72 
Key words: Vitamin D / Implantation / Assisted reproductive treatments / In vitro fertilisation / 73 
Endometrial receptivity 74 
  75 
Page 4 of 65
http://humrep.oupjournals.org
Draft Manuscript Submitted to Human Reproduction for Peer Review
4 
 
INTRODUCTION 76 
Infertility causes great psychological and sometimes physical distress to one in seven couples 77 
(National Institute for Health and Care Excellence 2013). In the United Kingdom (UK), in 2014, 52,288 78 
women underwent 67,708 in vitro fertilization (IVF) treatment cycles (Human Fertility Embryology 79 
Authority 2016). The overall success rate of these assisted reproductive treatments (ART) was 36.3% 80 
(Human Fertility Embryology Authority 2016). Since the availability of ART treatment has become 81 
more widespread, success rates have gradually increased (Grady et al. 2012). This has largely been 82 
due to the research conducted in embryology, which has enhanced our abilities to select and 83 
transfer the embryo with the highest pregnancy potential. More recently, the rate of improvement 84 
in success rates has slowed (Busso et al. 2006). There remains ample room for improvement in 85 
fertility treatments to maximize the chances of achieving pregnancy. Much of this lies in improving 86 
the likelihood for implantation of the selected embryo that is transferred in to the uterus (Macklon 87 
et al. 2002).  88 
 89 
There has been recent interest in the role of vitamin D in reproductive physiology as findings have 90 
shown that as much as 20 to 52% of women of reproductive age are deficient in vitamin D (Gordon 91 
et al. 2004; Sullivan et al. 2005; Tangpricha et al. 2002). It is postulated that vitamin D is important in 92 
the process of pregnancy implantation as vitamin D enzymes and receptors have been found in the 93 
endometrium (Lerchbaum & Rabe 2014). Additionally, vitamin D deficiency has been found to cause 94 
decreased fertility capacity, hypogonadism and uterine hypoplasia in animal studies (Halloran & 95 
DeLuca 1980; Kinuta et al. 2000; Yoshizawa et al. 1997; Panda et al. 2001). In humans, the 96 
importance of vitamin D in placental function is the most studied aspect of vitamin D in reproduction 97 
(Aghajafari et al. 2013). Specifically, vitamin D deficiency has been linked to poor placentation, 98 
leading to hypertensive disorders of pregnancy (pre-eclampsia and pregnancy induced hypertension) 99 
and fetal growth restriction (Aghajafari et al. 2013). More recently, it has been proposed that 100 
vitamin D may be a regulator of initial embryo implantation and that improper implantation, due to 101 
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vitamin D deficiency, is the cause of poor placentation (Bodnar et al. 2007; Baker et al. 2010; 102 
Robinson et al. 2011). 103 
 104 
Our main source of vitamin D, a fat-soluble steroid hormone, is from sunlight. Only a small amount is 105 
obtained from our diet. The majority of the body’s vitamin D is in the form of vitamin D3 106 
(cholecalciferol), which is photo-chemically synthesized in the skin (Holick 2007).  107 
 108 
Vitamin D concentrations are usually measured by assay of serum 25-hydroxy vitamin D3 status. 109 
Experts in nutrition have suggested that people are at risk of the detrimental effects of vitamin D 110 
deficiency at serum 25-hydroxy vitamin D3 concentrations of less than 50 nmol/L (less than 111 
20ng/mL). A concentration of 50 to 75 nmol/L (21 to 29 ng/mL) is considered insufficient and greater 112 
than 75nmol/L (greater than 30 ng/ml) is considered vitamin D replete. These vitamin D 113 
concentration cut-offs are those adopted by the Endocrine Society (Holick et al. 2011). Differing 114 
vitamin D concentration cut-offs have also been proposed by the Institute of Medicine (IOM), who 115 
suggest that vitamin D deficiency is when serum 25-hydroxy vitamin D3 concentrations are less than 116 
30 nmol/L (less than 12ng/mL), vitamin D insufficency is when serum 25-hydroxy vitamin D3 117 
concentrations are between 30 nmol/L and 50nmol/L (between 12 and 20ng/mL), and that serum 118 
25-hydroxy vitamin D3 concentrations greater than 50nmol/L (greater than 20ng/mL) are considered 119 
replete (Ross et al. 2011). There is agreement that serum concentrations greater than 374 nmol/L 120 
(greater than 150 ng/mL) are associated with toxicity and adverse effects (Tangpricha et al. 2002; 121 
Heaney 2008; Stephanou et al. 1994; Daftary & Taylor 2006).   122 
 123 
The biological plausibility that vitamin D plays an important role in implantation has led research 124 
groups to investigate the importance of vitamin D in patients undergoing ART. Some studies have 125 
found that replete concentrations of vitamin D lead to an increase in clinical pregnancy and live birth 126 
rates (Rudick et al. 2014; Ozkan et al. 2010; Rudick et al. 2012; Garbedian et al. 2013; Paffoni et al. 127 
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2014). However, others have found conflicting evidence suggesting that vitamin D has no effect on 128 
the outcome of ART(Anifandis et al. 2010; Aleyasin et al. 2011; Firouzabadi et al. 2014; Fabris et al. 129 
2014; Franasiak et al. 2015). The aim of our review was to investigate the association between 130 
vitamin D status and reproductive outcomes by meta-analysis of the ART outcomes of published 131 
cohort studies to summarise the available evidence. 132 
METHODS 133 
Inclusion Criteria 134 
The study was designed a priori with inclusion of primary articles that studied women undergoing 135 
any form of ART (IVF, ICSI and frozen embryo transfer [FET]) who had their vitamin D status checked. 136 
This could either be through blood serum or follicular fluid assay. The primary outcome was live 137 
birth rates according to vitamin D status. Secondary outcomes included biochemical pregnancy 138 
rates, and clinical pregnancy rates. 139 
 140 
Literature search  141 
MEDLINE, EMBASE, Cochrane Central Register of Controlled Trials and CINAHL (from inception to 142 
April 2017) were searched. The search strategy used the following key words and/or medical subject 143 
heading (MeSH) terms: pregnancy, in vitro fertilization, intracytoplasmic sperm injection, assisted 144 
reproductive techniques and vitamin D. The full electronic search strategy is provided in 145 
Supplementary Table SI. References of all included primary and review articles were examined to 146 
identify relevant articles not captured by the electronic searches. No language restrictions were 147 
applied in any of the searches or study selection. 148 
 149 
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Study selection 150 
Criteria for inclusion in the study were established prior to the literature search. Two independent 151 
reviewers (J.C. and B.T.) carried out study selection. First, the independent reviewers scrutinized the 152 
titles and abstracts of the electronic searches. Each title and abstract were included or excluded 153 
independently according to the predefined inclusion criteria; any disagreements regarding inclusion 154 
were resolved by a further reviewer (I.D.G). The full manuscripts of the titles and abstracts 155 
considered to be relevant for inclusion were obtained. When there was a duplicate publication, the 156 
most recent and complete version was selected and included. Studies that did not explicitly report 157 
results from assisted reproductive treatments according to vitamin D groups (deficient, insufficient 158 
and replete) according to Endocrine Society guidelines were excluded. 159 
 160 
The same two independent reviewers (J.C. and B.T.) extracted the outcome data from the included 161 
studies.  162 
 163 
Study quality assessment 164 
Two reviewers (J.C and B.T.) used the Newcastle-Ottawa Quality Assessment Scales for observational 165 
studies to complete a quality assessment of the included manuscripts(Wells et al. 2011). The 166 
Newcastle-Ottawa scale ranges from zero to nine, awarding one star for all categories (case-cohort 167 
representative, ascertainment of exposure, outcome negative at commencement of study, outcome 168 
assessment, duration of follow up and adequacy of follow up) except comparability by design or 169 
analysis where two stars can be awarded. An arbitrary score was allocated assuming that all items 170 
have equal weighting. This was used to give a quantitative appraisal of overall quality of the 171 
individual studies. Each study received a score from each of the reviewers. 172 
 173 
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Publication Bias 174 
Assessment for publication bias in the included studies for the outcome of clinical pregnancy was 175 
performed using Harbord’s modified test for small study effects to assess for funnel plot asymmetry 176 
((Harbord et al. 2006). 177 
Statistical analysis  178 
Live birth, biochemical pregnancy, clinical pregnancy and miscarriage rates were extracted from 179 
each of the included studies according to vitamin D strata. The log of the ratio and its corresponding 180 
standard error for each study was computed. Meta-analysis using inverse-variance weighting was 181 
performed to calculate the random-effects summary estimates. The square root of this number is 182 
the estimated standard deviation of the underlying effects across studies. Because we had relative 183 
measures of effect, the confidence intervals were centered on the natural logarithm of the pooled 184 
estimate and the limits exponentiated to obtain an interval on the ratio scale. Forest plots were 185 
created for each outcome, showing individual study proportions with confidence intervals (CIs) and 186 
the overall DerSimmonian-Laird pooled estimate according to vitamin D status. Heterogeneity of the 187 
treatment effects was assessed graphically with forest plots and statistically analyzed using the χ
2
 188 
test. Statistical analyses were performed using Stata 12.1 (StataCorp, College Station, TX). 189 
RESULTS 190 
The PRISMA flow diagram (Liberati et al. 2009; Moher et al. 2009) of the review process is presented 191 
in Fig. 1. The search strategy yielded 4615 citations, of which 4505 citations were excluded as it was 192 
clear from scrutinizing the title and abstract that they did not fulfil the selection criteria. Full 193 
manuscripts of 110 articles were obtained. A total of 99 of these publications were excluded because 194 
35 were reviews, 24 articles did not specify outcomes from ART, 17 articles did not specify 195 
investigating vitamin D, seven articles were conference abstracts or studies where there was no 196 
extractable data (Farzadi et al. 2015; Neville et al. 2016) (as they provided mean vitamin D 197 
concentrations of groups of women achieving clinical pregnancy and those that did not) , five articles 198 
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reported male infertility, four articles were animal studies, three were letters, two were duplicates, 199 
and one was a study protocol. Therefore, the total number of observational studies included in the 200 
review was 11. 201 
 202 
Study characteristics 203 
Study characteristics of the 11 included studies are presented in Table I. None of the included 204 
studies declared any conflicts of interest. The included studies varied in publication date between 205 
2010 and 2015. All 11 included studies were cohort studies; six were retrospective and five were 206 
prospective in design. Sample sizes varied between 84 women to 517 women. Nine of the 11 207 
included studies reported the ages of their study population. Seven studies had a mean age of below 208 
37 years and two had a higher mean age of 40.5 and 40.9 years. Eight included studies used serum 209 
measurement of vitamin D, two used both follicular fluid and serum vitamin D (finding that there 210 
was high correlation between the follicular fluid vitamin D and serum vitamin D in their participants), 211 
and one study used follicular fluid alone. Of the 11 included studies, nine studies reported ART 212 
where women had used autologous oocytes. Two reported results from women who were donor 213 
egg recipients. One study used pre-implantation genetic screening to ensure that patients had 214 
karyotypically normal embryos transferred. One study chose to only study women that underwent a 215 
single blastocyst transfer. All of the 11 included studies assayed 25-hydroxy-vitamin D. Four of the 216 
included studies assessed vitamin D before the commencement of the treatment cycle, three 217 
assessed vitamin D at the time of ovulation trigger, three assessed vitamin D at the time of oocyte 218 
retrieval, and one study assessed vitamin D just before oocyte retrieval. All of the 11 included 219 
studies used the Endocrine Society classification of vitamin D status (less than 50nmol/L deficient, 220 
50-75nmol/L insufficient, and greater than 75nmolL replete). Six of the included studies provided 221 
adjusted odds ratios, adjusting for potential confounding factors. Of these six studies, only four 222 
provided adequate detail for potential meta-analysis of adjusted odds ratios. However, two of these 223 
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studies had adjusted for vitamin D concentration and another two studies had used differing 224 
referent groups to obtain adjusted odds ratios. 225 
 226 
A funnel plot to test for asymmetry did not find substantial evidence of publication bias (p=0.933) 227 
(Supplementary Figure S1). 228 
 229 
All studies scored well using the Newcastle-Ottawa Quality Assessment achieving a score between 7 230 
and 9 (Table II). 231 
 232 
 233 
Vitamin D deficiency prevalence 234 
Our review found a high prevalence of vitamin D deficiency. The meta-analysed prevalence for 235 
vitamin D deficiency, insufficiency and replete were 34.6% (95% CI 32.0 to 37.4), 45.3% (95% CI 42.4 236 
to 48.5) and 25.7% (95% CI 23.4 to 28.2%) respectively. 237 
 238 
Live birth  239 
Seven studies (2026 participants) reported the live births achieved by women when categorized by 240 
vitamin D (Fig. 2). Meta-analysis of the data from these studies showed that women who are vitamin 241 
D replete have a higher chance of achieving a live birth from ART when compared with women with 242 
vitamin D deficiency or insufficiency. The odds ratio was 1.33 (1.08 to 1.65). The meta-analysis had 243 
low statistical heterogeneity with an I
2
 value of 5.0% (p=0.39).  244 
 245 
Biochemical pregnancy  246 
Five studies (1700 participants) reported the number of women that achieved a positive pregnancy 247 
test approximately two weeks after embryo transfer for the three vitamin D categories. The odds of 248 
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biochemical pregnancy in the vitamin D deficient and insufficient population versus the vitamin D 249 
replete population are presented in Fig. 3. Meta-analysis of these five cohort studies showed a 250 
greater chance of pregnancy in the vitamin D replete group when compared with the vitamin D 251 
deficient and insufficient groups with an odds ratio of 1.34 (1.04 to 1.73). There was a low level of 252 
statistical heterogeneity with an I
2
 value of 21.0% (p=0.28).  253 
 254 
Clinical pregnancy  255 
All 11 studies (2700 participants) reported on clinical pregnancy rate (the presence of fetal heart 256 
approximately five weeks after embryo transfer) as an outcome (Fig. 4). Pooling of the clinical 257 
pregnancy outcomes from the 11 studies showed an improved chance of clinical pregnancy in the 258 
vitamin D replete population when compared with the vitamin D deficient and insufficient 259 
population. The vitamin D replete group was more likely to achieve clinical pregnancy when 260 
compared with the vitamin D deficient and insufficient groups with an odds ratio of 1.46 (1.05 to 261 
2.02). The I
2
 value for this meta-analysis was 61.0% suggesting a moderate level of statistical 262 
heterogeneity (p=0.02). 263 
 264 
Data could be extracted from nine of the included studies (2082 patients) to compare the chances of 265 
clinical pregnancy by using the IOM definitions of vitamin D status (vitamin D concentrations of less 266 
than 50nmol/L considered as deficient or insufficient and vitamin D concentrations of more than 267 
50nmol/L considered replete). Pooling of the clinical pregnancy rates from these nine studies also 268 
showed that women with a vitamin D concentration of greater than 50nmol/L were more likely to 269 
achieve a clinical pregnancy when compared to women with a vitamin D concentration of below 270 
50nmol/L with an odds ratio of 1.38 (1,04 to 1.83) (Supplementary Figure S2). 271 
 272 
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Clinical pregnancy according to source of oocyte used 273 
The 11 included studies were divided into two groups according to the source of the oocyte 274 
(autologous or donor) used to form the embryo for transfer (Fig. 5). Nine studies (including 2334 275 
patients) reported fertility outcomes in infertile women receiving an autologous oocyte embryo. 276 
Clinical pregnancy was found to be more likely in women who were vitamin D replete who received 277 
an autologous oocyte embryo (OR 1.39 [1.00 to 1.93]). The I
2
 value for this meta-analysis was 56.0% 278 
suggesting a moderate level of statistical heterogeneity (p=0.02). 279 
 280 
In the two studies (including 366 patients) where women received a donor oocyte embryo, no 281 
significant difference was found when comparing the clinical pregnancy in women receiving a donor 282 
oocyte embryo who were vitamin D replete when compared to women who were vitamin D 283 
deficient or insufficient (OR 2.02 [0.44 to 9.26]). The I
2
 value for this meta-analysis was 85.0% 284 
suggesting a considerable level of statistical heterogeneity (p=0.009). 285 
 286 
Miscarriage  287 
Six studies (1635 participants) reported on the outcome of miscarriage (Fig. 6). When the data from 288 
these six studies are pooled, the chance of miscarriage in the vitamin D replete women is similar to 289 
that of vitamin D deficient and insufficient women with an odds ratio of 1.12 (0.81 to 1.54). There 290 
was a low level of statistical heterogeneity denoted by an I
2
 value of 0.0% (p=0.76).  291 
 292 
DISCUSSION 293 
This systematic review including 11 studies suggests that the chances of achieving a live birth, a 294 
positive pregnancy test and clinical pregnancy after ART are higher in women who are vitamin D 295 
replete when compared to those who are vitamin D deficient or insufficient. Miscarriage does not 296 
appear to be associated with vitamin D status. 297 
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 298 
Our analysis was strengthened by a number of factors. A comprehensive search strategy was used, 299 
employing relevant research databases. Additionally, a valid data synthesis method was 300 
implemented and no language restrictions were applied. The Newcastle-Ottawa Quality Assessment 301 
Scale was used to assess the quality of the included studies. The assessment of all studies scored 302 
well on this scale, suggesting low risk of bias. 303 
 304 
There are also weaknesses in our analysis, which mainly stem from the clinical heterogeneity of the 305 
publications that were included. Some degree of heterogeneity is to be expected due to the 306 
different geographical locations that the individual cohort studies have been conducted, leading to 307 
differing population characteristics and ART protocols used. However, this is not necessarily a 308 
disadvantage as some degree of clinical heterogeneity can increase the generalisability of the 309 
findings to wider infertility populations.  310 
 311 
Ideally, when meta-analysing cohort studies, the adjusted odds ratios (where provided) should be 312 
meta-analysed. However, in our included studies it was infrequent for the included primary studies 313 
to have provided sufficient detail of their adjusted analysis for known confounding factors such as 314 
age and BMI. Therefore, we were unable to perform a meta-analysis of adjusted odds ratios.  315 
 316 
One source of clinical heterogeneity between the included studies is in the timing of vitamin D 317 
assessment. Some of the studies measured their participants’ vitamin D status before the start of 318 
ART, whereas others measured vitamin D at the time of oocyte retrieval. Vitamin D status is known 319 
to not fluctuate over time unless vitamin D deficiency or insufficiency is actually treated (Anagnostis 320 
et al. 2013). Therefore, the importance of the difference in timing of the vitamin D assessment 321 
reduces. 322 
 323 
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There were also differences in the bio-fluid used to assess vitamin D status amongst the included 324 
studies. Three of the included studies measured vitamin D in the follicular fluid aspirated at the time 325 
of oocyte retrieval. The remaining studies used blood serum for vitamin D measurement. 326 
Reassuringly, a number of previously published studies have found that assays of vitamin D in 327 
follicular fluid or blood serum produce results that are highly correlative (Aleyasin et al. 2011; 328 
Anifandis et al. 2010; Firouzabadi et al. 2014; Ozkan et al. 2010). Serum vitamin D would be 329 
measured more conveniently in women undergoing ART and could be tested before the start of 330 
treatment to allow time for correction of deficiency.  331 
 332 
We found that the likelihood of achieving a positive pregnancy test after embryo transfer was higher 333 
in women who were replete in vitamin D. This would support the hypothesis that vitamin D affects 334 
embryo implantation. Two of the included studies have tried to investigate the effect of vitamin D on 335 
implantation further by only including women undergoing oocyte recipient treatment cycles (Fabris 336 
et al. 2014; Rudick et al. 2014). Isolating recipients of donor oocyte embryos aims to reduce the 337 
impact of oocyte quality on reproductive outcomes. Donated oocytes would be sourced from 338 
younger women with higher quality oocytes and therefore implantation can be investigated more 339 
accurately. Meta-analysis of the clinical pregnancy data from these two studies (including 366 340 
patients) did not show a statistically significant difference in chance of clinical pregnancy between 341 
the vitamin D replete and vitamin D deficient or insufficient populations. However, the data may 342 
suggest a higher chance of clinical pregnancy in the vitamin D replete group. It is likely that the 343 
failure to reach statistical significance is due to the low number of participants in view of the wide 344 
confidence intervals (Schünemann et al. 2011). Removal of these two studies from the overall 345 
analysis did not alter the overall association between vitamin D concentration and clinical 346 
pregnancy.  347 
 348 
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Seasonal variations in conception rates have been established (Rojansky et al. 1992) with higher 349 
conception rates found in the Summer and Autumn. Although many hypotheses have been 350 
postulated to explain this phenomenon (e.g. reduced ovulation rates and poorer sperm quality in 351 
darker months) the exact mechanism behind this has not been explained. It is possible that an 352 
increase in sun exposure and greater sunlight luminosity increases the body’s store of vitamin D, 353 
thereby yielding higher conception rates in Summer and Autumn. 354 
 355 
Although the debate regarding the importance of vitamin D and seasonal variation in reproductive 356 
health continues, its impact on immunomodulation within the endometrium with a resultant 357 
reduction in active inflammatory cytokines is now well understood (Holick 2007). The expression of 358 
vitamin D receptors at the level of the endometrium and the role of vitamin D in the transcription of 359 
HOX10A gene (found to be of key importance in implantation) suggest that the immunomodulatory 360 
effects of vitamin D may have a direct impact on implantation and therefore the likelihood of 361 
reproductive treatment success (Evans et al. 2004). 362 
 363 
Ethnicity has also been found to be a prognostic marker for IVF treatment success, with women of 364 
Asian and Black ethnic origins having worse reproductive outcomes (Dhillon et al. 2016). One 365 
possible explanation for this finding could be lower serum vitamin D concentrations in these ethnic 366 
groups or differences in the vitamin D receptor gene polymorphisms (Ingles 2007; John et al. 2007).  367 
 368 
Our review demonstrates that replete vitamin D status is associated with greater chances of ART 369 
success. This could be via the actions of vitamin D on the endometrium promoting embryo 370 
implantation or as a surrogate marker for general well-being (Lerchbaum & Rabe 2014). Vitamin D 371 
serum testing is relatively cheap and widely available and its treatment is not costly. Therefore it 372 
may be beneficial to diagnose and treat vitamin D deficiency in women planning ART to optimize 373 
their pregnancy outcomes. Correction of vitamin D deficiency in these patients would also be of 374 
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benefit during pregnancy, as replete vitamin D concentrations have been found to reduce the risk of 375 
obstetric complications such as gestational diabetes (Wang et al. 2012; Zhang et al. 2015), pre-376 
eclampsia (Moon et al. 2015; De-Regil et al. 2012; Wei 2014), and fetal growth restriction (Conde-377 
Agudelo et al. 2013; Khalessi et al. 2015). To further investigate the value of treatment of vitamin D 378 
deficiency in the infertile population an interventional trial would be necessary. 379 
Acknowledgments 380 
The authors would like to acknowledge Derick Yates (Birmingham Women’s and Children’s NHS 381 
Foundation Trust) who helped design the search strategy for the systematic review and meta-382 
analysis. 383 
 384 
Authors’ roles 385 
JC and AC were responsible for defining the research question. JC designed the strategy for literature 386 
search.  JC and BT assessed eligibility of studies for inclusion to the systematic review. Statistical 387 
analyses were performed by AT and IDG. AE assisted in the design of the systematic review search 388 
strategy and in manuscript preparation. JC wrote the first draft of the manuscript and is its 389 
guarantor. All authors revised it critically for important intellectual content and gave final approval 390 
of the version to be published. 391 
 392 
Funding 393 
No external funding was either sought or obtained for this study. 394 
 395 
Conflicts of interest 396 
None to declare 397 
  398 
Page 17 of 65
http://humrep.oupjournals.org
Draft Manuscript Submitted to Human Reproduction for Peer Review
17 
 
References 399 
Aghajafari, F. et al., 2013. Association between maternal serum 25-hydroxyvitamin D level and 400 
pregnancy and neonatal outcomes: systematic review and meta-analysis of observational 401 
studies. BMJ, 346, p.f1169. Available at: 402 
http://www.ncbi.nlm.nih.gov/pubmed/23533188\nhttp://www.bmj.com/content/bmj/346/b403 
mj.f1169.full.pdf. 404 
Aleyasin, A. et al., 2011. Predictive value of the level of vitamin D in follicular fluid on the outcome of 405 
assisted reproductive technology. Eur J Obstet Gynecol Reprod Biol, 159(1), pp.132–137. 406 
Anagnostis, P., Karras, S. & Goulis, D.G., 2013. Vitamin D in human reproduction: A narrative review. 407 
International Journal of Clinical Practice, 67(3), pp.225–235. 408 
Anifandis, G.M. et al., 2010. Prognostic value of follicular fluid 25-OH vitamin D and glucose levels in 409 
the IVF outcome. Reproductive biology and endocrinology : RB&E, 8, p.91. 410 
Baker, A.M. et al., 2010. A Nested Case-Control Study of Midgestation Vitamin D Deficiency and Risk 411 
of Severe Preeclampsia. The Journal of Clinical Endocrinology & Metabolism, 95(11), pp.5105–412 
5109. Available at: http://press.endocrine.org/doi/abs/10.1210/jc.2010-0996. 413 
Bodnar, L.M. et al., 2007. Maternal vitamin D deficiency increases the risk of preeclampsia. The 414 
Journal of clinical endocrinology and metabolism, 92(9), pp.3517–22. Available at: 415 
http://press.endocrine.org/doi/full/10.1210/jc.2007-0718. 416 
Busso, C.E. et al., 2006. Implantation in IVF. International Surgery, 91(5 SUPPL.). 417 
Conde-Agudelo, A. et al., 2013. Novel biomarkers for predicting intrauterine growth restriction: A 418 
systematic review and meta-analysis. BJOG: An International Journal of Obstetrics and 419 
Gynaecology, 120(6), pp.681–694. 420 
Daftary, G.S. & Taylor, H.S., 2006. Endocrine regulation of HOX genes. Endocrine Reviews, 27(4), 421 
pp.331–355. 422 
De-Regil, L.M. et al., 2012. Vitamin D supplementation for women during pregnancy. Cochrane 423 
database of systematic reviews (Online), 2(2), p.CD008873. Available at: 424 
Page 18 of 65
http://humrep.oupjournals.org
Draft Manuscript Submitted to Human Reproduction for Peer Review
18 
 
http://onlinelibrary.wiley.com/doi/10.1002/14651858.CD008873.pub2/pdf/standard\nhttp://425 
www.ncbi.nlm.nih.gov/pubmed/22336854. 426 
Dhillon, R.K. et al., 2016. Predicting the chance of live birth for women undergoing IVF: a novel 427 
pretreatment counselling tool. Human Reproduction, 31(1), pp.84–92. Available at: 428 
http://humrep.oxfordjournals.org/lookup/doi/10.1093/humrep/dev268. 429 
Evans, K.N. et al., 2004. Vitamin D and placental-decidual function. Journal of the Society for 430 
Gynecologic Investigation, 11(5), pp.263–271. 431 
Fabris, A. et al., 2014. Impact of circulating levels of total and bioavailable serum vitamin D on 432 
pregnancy rate in egg donation recipients. Fertility and Sterility, 102(6), pp.1608–1612. 433 
Farzadi, L., Khayatzadeh Bidgoli, H. & Ghojazadeh, M., 2015. Correlation between follicular fluid 25-434 
OH vitamin D and assisted reproductive outcomes. Iranian Journal of Reproductive Medicine, 435 
13(6), pp.361–366. 436 
Firouzabadi, R.D. et al., 2014. Value of follicular fluid vitamin D in predicting the pregnancy rate in an 437 
IVF program. Archives of Gynecology and Obstetrics, 289(1), pp.201–206. 438 
Franasiak, J.M. et al., 2015. Vitamin D levels do not affect IVF outcomes following the transfer of 439 
euploid blastocysts. American Journal of Obstetrics and Gynecology, 212(3), pp.315.e1–315.e6. 440 
Garbedian, K. et al., 2013. Effect of vitamin D status on clinical pregnancy rates following in vitro 441 
fertilization. CMAJ Open, 1(2), pp.E77–82. Available at: 442 
http://www.ncbi.nlm.nih.gov/pubmed/25077107. 443 
Gordon, C.M. et al., 2004. Prevalence of vitamin D deficiency among healthy adolescents. Archives of 444 
pediatrics & adolescent medicine, 158(6), pp.531–537. 445 
Grady, R. et al., 2012. Elective single embryo transfer and perinatal outcomes: A systematic review 446 
and meta-analysis. Fertility and Sterility, 97(2), pp.324–331. 447 
Halloran, B.P. & DeLuca, H.F., 1980. Effect of vitamin D deficiency on fertility and reproductive 448 
capacity in the female rat. J Nutr, 110(8), pp.1573–1580. 449 
Harbord, R.M., Egger, M. & Sterne, J.., 2006. A modified test for small study effects in meta-analyses 450 
Page 19 of 65
http://humrep.oupjournals.org
Draft Manuscript Submitted to Human Reproduction for Peer Review
19 
 
of controlled trials with binary endpoints. Stat. Med, 25, pp.3443–3457. 451 
Heaney, R.P., 2008. Vitamin D in health and disease. Clinical journal of the American Society of 452 
Nephrology : CJASN, 3(5), pp.1535–41. Available at: 453 
http://www.ncbi.nlm.nih.gov/pubmed/18525006. 454 
Holick, M.F. et al., 2011. Evaluation, treatment, and prevention of vitamin D deficiency: an Endocrine 455 
Society clinical practice guideline. The Journal of clinical endocrinology and metabolism, 96(7), 456 
pp.1911–30. Available at: http://www.ncbi.nlm.nih.gov/pubmed/21646368. 457 
Holick, M.F., 2007. Vitamin D deficiency. The New England journal of medicine, 357(3), pp.266–281. 458 
Available at: http://www.ncbi.nlm.nih.gov/pubmed/17634462. 459 
Human Fertility Embryology Authority, 2016. Fertility Treatment 2014, 460 
Ingles, S.A., 2007. Can Diet and/or Sunlight Modify the Relationship between Vitamin D Receptor 461 
Polymorphisms and Prostate Cancer Risk? Nutrition Reviews, 65(SUPPL.2). 462 
John, E.M. et al., 2007. Sun exposure, vitamin D receptor gene polymorphisms, and breast cancer 463 
risk in a multiethnic population. American Journal of Epidemiology, 166(12), pp.1409–1419. 464 
Khalessi, N. et al., 2015. The Relationship between Maternal Vitamin D Deficiency and Low Birth 465 
Weight Neonates. Journal of family & reproductive health, 9(3), pp.113–117. Available at: 466 
http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=4662754&tool=pmcentrez&rende467 
rtype=abstract\nhttp://www.ncbi.nlm.nih.gov/pubmed/26622309\nhttp://www.pubmedcentr468 
al.nih.gov/articlerender.fcgi?artid=PMC4662754. 469 
Kinuta, K. et al., 2000. Vitamin D is an important factor in estrogen biosynthesis of both female and 470 
male gonads. Endocrinology, 141(4), pp.1317–1324. 471 
Lerchbaum, E. & Rabe, T., 2014. Vitamin D and female fertility. Current opinion in obstetrics & 472 
gynecology, 26(3), pp.145–50. Available at: http://www.ncbi.nlm.nih.gov/pubmed/24717915. 473 
Liberati, A. et al., 2009. Annals of Internal Medicine Academia and Clinic The PRISMA Statement for 474 
Reporting Systematic Reviews and Meta-Analyses of Studies That Evaluate Health Care 475 
Interventions : Annals of Internal Medicine, 151(4), pp.W65–W94. 476 
Page 20 of 65
http://humrep.oupjournals.org
Draft Manuscript Submitted to Human Reproduction for Peer Review
20 
 
Macklon, N.S., Geraedts, J.P.M. & Fauser, B.C.J.M., 2002. Conception to ongoing pregnancy: The 477 
“black box” of early pregnancy loss. Human Reproduction Update, 8(4), pp.333–343. 478 
Moher, D. et al., 2009. Reprint--preferred reporting items for systematic reviews and meta-analyses: 479 
the PRISMA statement. Physical therapy, 89(9), pp.873–880. 480 
Moon, R.J., Harvey, N.C. & Cooper, C., 2015. ENDOCRINOLOGY IN PREGNANCY: Influence of maternal 481 
vitamin D status on obstetric outcomes and the fetal skeleton. European Journal of 482 
Endocrinology, 173(2), pp.R69–R83. 483 
National Institute for Health and Care Excellence, N., 2013. Fertility: assessment and treatment for 484 
people with fertility problems. NICE CLincal Guidelines, (May), p.274–. Available at: 485 
http://scholar.google.com/scholar?hl=en&btnG=Search&q=intitle:Fertility+:+assessment+and+486 
treatment+for+people+with+fertility+problems#0\nhttp://scholar.google.com/scholar?hl=en&487 
btnG=Search&q=intitle:Fertility:+assessment+and+treatment+for+people+with+fert. 488 
Neville, G. et al., 2016. Vitamin D status and fertility outcomes during winter among couples 489 
undergoing in vitro fertilization/intracytoplasmic sperm injection. Int J Gynaecol Obstet., 490 
135(2), pp.172–176. 491 
Ozkan, S. et al., 2010. Replete vitamin D stores predict reproductive success following in vitro 492 
fertilization. Fertility and Sterility, 94(4), pp.1314–1319. 493 
Paffoni, A. et al., 2014. Vitamin D deficiency and infertility: Insights from in vitro fertilization cycles. 494 
Journal of Clinical Endocrinology and Metabolism, 99(11), pp.E2372–E2376. 495 
Panda, D.K. et al., 2001. Targeted ablation of the 25-hydroxyvitamin D 1alpha -hydroxylase enzyme: 496 
evidence for skeletal, reproductive, and immune dysfunction. Proceedings of the National 497 
Academy of Sciences of the United States of America, 98(13), pp.7498–7503. 498 
Robinson, C.J. et al., 2011. Maternal vitamin D and fetal growth in early-onset severe preeclampsia. 499 
American Journal of Obstetrics and Gynecology, 204(6). 500 
Rojansky, N., Brzezinski, A. & Schenker, J.G., 1992. Seasonality in human reproduction: an update. 501 
Human Reproduction, 7(6), pp.735–745. 502 
Page 21 of 65
http://humrep.oupjournals.org
Draft Manuscript Submitted to Human Reproduction for Peer Review
21 
 
Ross, A., Manson, J. & Abrams, S., 2011. The 2011 Report on Dietary Reference Intakes for Calcium 503 
and Vitamin D from the Institute of Medicine: What Clinicians Need to Know. The Journal of 504 
Clinical Endocrinology and Metabolism, 96(1), pp.53–58. 505 
Rudick, B. et al., 2012. Characterizing the influence of vitamin D levels on IVF outcomes. Human 506 
Reproduction, 27(11), pp.3321–3327. 507 
Rudick, B. et al., 2010. Characterizing the role of vitamin D levels on IVF outcomes: stimulation, 508 
embryo, or endometrium? Fertility and Sterility, 94(4), p.S72. Available at: 509 
http://linkinghub.elsevier.com/retrieve/pii/S0015028210013853. 510 
Rudick, B.J. et al., 2014. Influence of vitamin D levels on in vitro fertilization outcomes in donor-511 
recipient cycles. Fertility and Sterility, 101(2), pp.447–452. 512 
Schünemann, H. et al., 2011. Cochrane Handbook for Systematic Reviews of Interventions Version 513 
5.1.0. In Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0. 514 
Stephanou, A., Ross, R. & Handwerger, S., 1994. Regulation of Human Placental Lactogen Expression 515 
by 1,25-Dihydroxyvitamin D3. Endocrinology, 135(6), pp.2651–2656. 516 
Sullivan, S.S. et al., 2005. Adolescent girls in maine are at risk for vitamin D insufficiency. Journal of 517 
the American Dietetic Association, 105(6), pp.971–974. 518 
Tangpricha, V. et al., 2002. Vitamin D insufficiency among free living healthy young adults. American 519 
Journal of Medicine, 112(8), pp.659–662. 520 
Wang, O. et al., 2012. Association between vitamin D insufficiency and the risk for gestational 521 
diabetes mellitus in pregnant Chinese women. Biomedical and environmental sciences : BES, 522 
25(4), pp.399–406. Available at: http://www.ncbi.nlm.nih.gov/pubmed/23026519. 523 
Wei, S.Q., 2014. Vitamin D and pregnancy outcomes. Current opinion in obstetrics & gynecology, 524 
26(6), pp.438–47. Available at: http://www.ncbi.nlm.nih.gov/pubmed/25310531. 525 
Wells, G. et al., 2011. The Newcastle-Ottawa Scale (NOS) for assessing the quality of nonrandomised 526 
studies in meta-analysis. 2011. , p.http://www.ohri.ca/programs/clinical_epidemiolog. 527 
Yoshizawa, T. et al., 1997. Mice lacking the vitamin D receptor exhibit impaired bone formation, 528 
Page 22 of 65
http://humrep.oupjournals.org
Draft Manuscript Submitted to Human Reproduction for Peer Review
22 
 
uterine hypoplasia and growth retardation after weaning. Nature genetics, 16(4), pp.391–396. 529 
Available at: 530 
http://www.ncbi.nlm.nih.gov/pubmed/9241280\nhttp://www.nature.com/ng/journal/v16/n4/531 
abs/ng0897-391.html. 532 
Zhang, M.X. et al., 2015. Vitamin D deficiency increases the risk of gestational diabetes mellitus: A 533 
meta-analysis of observational studies. Nutrients, 7(10), pp.8366–8375. Available at: 534 
http://ovidsp.ovid.com/ovidweb.cgi?T=JS&CSC=Y&NEWS=N&PAGE=fulltext&D=emed13&AN=2535 
015431828\nhttp://sfx.ucl.ac.uk/sfx_local?sid=OVID:embase&id=pmid:&id=doi:10.3390/nu710536 
5398&issn=2072-6643&isbn=&volume=7&issue=10&spage=8366&pages=8366-537 
8375&date=2015&title. 538 
 539 
 540 
541 
Page 23 of 65
http://humrep.oupjournals.org
Draft Manuscript Submitted to Human Reproduction for Peer Review
23 
 
Figure Legends 542 
Figure 1. PRISMA flow diagram for study selection. 543 
 544 
Figure 2. Meta-analysis of studies reporting live birth by vitamin D concentrations. Meta-analysis of 545 
the data from seven included studies that reported live birth as an outcome showed that women 546 
who are vitamin D replete have a higher chance of achieving a live birth from ART when compared 547 
with women with vitamin D deficiency or insufficiency. F-H, Fixed; Fixed effects (Mantel-Haenszel)  548 
 549 
Figure 3. Meta-analysis of studies reporting biochemical pregnancy by vitamin D concentrations. 550 
Meta-analysis of the data from five included studies that reported biochemical pregnancy as an 551 
outcome showed that women who are vitamin D replete have a higher chance of achieving a 552 
positive pregnancy test from ART when compared with women with vitamin D deficiency or 553 
insufficiency. 554 
 555 
Figure 4. Meta-analysis of studies reporting clinical pregnancy by vitamin D concentrations. Meta-556 
analysis of the data from all 11 of the included studies that reported clinical pregnancy as an 557 
outcome showed that women who are vitamin D replete have a higher chance of achieving clinical 558 
pregnancy from ART when compared with women with vitamin D deficiency or insufficiency. 559 
 560 
Figure 5. Meta-analysis of studies reporting clinical pregnancy by vitamin D concentrations according 561 
to source of oocyte. Meta-analysis of the data from nine included studies showed that women who 562 
are vitamin D replete have a higher chance of achieving a clinical pregnancy from ART using 563 
autologous oocytes when compared with women with vitamin D deficiency or insufficiency. Meta-564 
analysis of the data from two included studies showed no difference in the chance of clinical 565 
pregnancy in women replete, insufficient or deficient in vitamin D undergoing ART using donor 566 
oocytes. 567 
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 568 
Figure 6. Meta-analysis of studies reporting miscarriage by vitamin D concentrations. Meta-analysis 569 
of the data from six included studies that reported miscarriage as an outcome showed no difference 570 
in the chance of miscarriage in women replete, insufficient or deficient in vitamin D undergoing ART. 571 
 572 
Supplementary Figure S1. Vitamin D and in vitro fertilisation treatment clinical pregnancy outcomes 573 
publication bias funnel plot. The funnel plot to test for asymmetry showed no substantial evidence 574 
of publication bias. 575 
 576 
Supplementary Figure S2. Meta-analysis of studies reporting clinical pregnancy by vitamin D 577 
concentrations implementing Institute of Medicine cut-offs. Data could be extracted from nine of 578 
the included studies to compare the chances of clinical pregnancy by using the Institute of Medicine 579 
definitions of vitamin D status (vitamin D concentrations of less than 50nmol/L considered as 580 
deficient or insufficient and vitamin D concentrations of more than 50nmol/L considered replete). 581 
Meta-analysis of the data from these nine studies showed that women who are vitamin D replete 582 
have a higher chance of achieving clinical pregnancy from ART when compared with women with 583 
vitamin D deficiency or insufficiency according to Institute of Medicine vitamin D cut-offs. 584 
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ABSTRACT  24 
 25 
Study question: Is serum vitamin D associated with live birth rates in women undergoing assisted 26 
reproductive treatment? 27 
 28 
Summary answer: Women undergoing assisted reproductive treatment who are replete in vitamin D 29 
have a higher live birth rate than women who are vitamin D deficient or insufficient. 30 
 31 
What is known already: Vitamin D deficiency has been associated with an increased risk of 32 
abnormal pregnancy implantation as well as obstetric complications such as pre-eclampsia and fetal 33 
growth restriction. However, the effect of vitamin D on conception and early pregnancy outcomes in 34 
couples undergoing assisted reproductive treatment is poorly understood. 35 
 36 
Study design, size, duration: A systematic review and meta-analysis of 11 published cohort studies 37 
(including 2700 women) investigating the association between vitamin D and assisted reproductive 38 
treatment outcomes. 39 
 40 
Participants/materials, settings, methods:  Literature searches were conducted to retrieve studies 41 
which reported on the association between vitamin D and assisted reproductive treatment 42 
outcomes. Databases searched included MEDLINE, EMBASE, Cochrane Central Register of Controlled 43 
Trials and CINAHL. Eleven studies matched the inclusion criteria. 44 
 45 
Main results and the role of chance: Live birth was reported in seven of the included studies 46 
(including 2026 patients). Live birth was found to be more likely in women replete in vitamin D when 47 
compared to women with deficient or insufficient vitamin D status (OR 1.33 [1.08 to 1.65]). Five 48 
studies (including 1700 patients) found that women replete in vitamin D were more likely to achieve 49 
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a positive pregnancy test than women deficient or insufficient in vitamin D (OR 1.34 ([1.04 to 1.73]). 50 
All 11 of the included studies (including 2700 patients) reported clinical pregnancy as an outcome. 51 
Clinical pregnancy was found to be more likely in women replete in vitamin D (OR 1.46[1.05 to 52 
2.02]). Six studies (including 1635 patients) reported miscarriage by vitamin D concentrations. There 53 
was no association found between miscarriage and vitamin D concentrations (OR 1.12 [0.81 to 1.54]. 54 
The included studies scored well on the Newcastle Ottawa quality assessment scale.  55 
 56 
Limitations, reasons for caution: Although strict inclusion criteria were used in the conduct of the 57 
systematic review, the included studies are heterogeneous in population characteristics and fertility 58 
treatment protocols. 59 
 60 
Wider implications of the findings: The findings of this systematic review show that there is an 61 
association between vitamin D status and reproductive treatment outcomes achieved in women 62 
undergoing assisted reproductive treatment. Our results show that vitamin D deficiency and 63 
insufficiency could be important conditions to treat in women considering assisted reproductive 64 
treatments. A randomised controlled trial to investigate the benefits of vitamin D deficiency 65 
treatment should be considered to test this hypothesis. 66 
 67 
Study funding/competing interests: No external funding was either sought or obtained for this 68 
study. The authors have no competing interests to declare.  69 
 70 
Registration number: N/A 71 
 72 
Key words: Vitamin D / Implantation / Assisted reproductive treatments / In vitro fertilisation / 73 
Endometrial receptivity 74 
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INTRODUCTION 76 
Infertility causes great psychological and sometimes physical distress to one in seven couples 77 
(National Institute for Health and Care Excellence 2013). In the United Kingdom (UK), in 2014, 52,288 78 
women underwent 67,708 in vitro fertilization (IVF) treatment cycles (Human Fertility Embryology 79 
Authority 2016). The overall success rate of these assisted reproductive treatments (ART) was 36.3% 80 
(Human Fertility Embryology Authority 2016). Since the availability of ART treatment has become 81 
more widespread, success rates have gradually increased (Grady et al. 2012). This has largely been 82 
due to the research conducted in embryology, which has enhanced our abilities to select and 83 
transfer the embryo with the highest pregnancy potential. More recently, the rate of improvement 84 
in success rates has slowed (Busso et al. 2006). There remains ample room for improvement in 85 
fertility treatments to maximize the chances of achieving pregnancy. Much of this lies in improving 86 
the likelihood for implantation of the selected embryo that is transferred in to the uterus (Macklon 87 
et al. 2002).  88 
 89 
There has been recent interest in the role of vitamin D in reproductive physiology as findings have 90 
shown that as much as 20 to 52% of women of reproductive age are deficient in vitamin D (Gordon 91 
et al. 2004; Sullivan et al. 2005; Tangpricha et al. 2002). It is postulated that vitamin D is important in 92 
the process of pregnancy implantation as vitamin D enzymes and receptors have been found in the 93 
endometrium (Lerchbaum & Rabe 2014). Additionally, vitamin D deficiency has been found to cause 94 
decreased fertility capacity, hypogonadism and uterine hypoplasia in animal studies (Halloran & 95 
DeLuca 1980; Kinuta et al. 2000; Yoshizawa et al. 1997; Panda et al. 2001). In humans, the 96 
importance of vitamin D in placental function is the most studied aspect of vitamin D in reproduction 97 
(Aghajafari et al. 2013). Specifically, vitamin D deficiency has been linked to poor placentation, 98 
leading to hypertensive disorders of pregnancy (pre-eclampsia and pregnancy induced hypertension) 99 
and fetal growth restriction (Aghajafari et al. 2013). More recently, it has been proposed that 100 
vitamin D may be a regulator of initial embryo implantation and that improper implantation, due to 101 
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vitamin D deficiency, is the cause of poor placentation (Bodnar et al. 2007; Baker et al. 2010; 102 
Robinson et al. 2011). 103 
 104 
Our main source of vitamin D, a fat-soluble steroid hormone, is from sunlight. Only a small amount is 105 
obtained from our diet. The majority of the body’s vitamin D is in the form of vitamin D3 106 
(cholecalciferol), which is photo-chemically synthesized in the skin (Holick 2007).  107 
 108 
Vitamin D concentrations are usually measured by assay of serum 25-hydroxy vitamin D3 status. 109 
Experts in nutrition have suggested that people are at risk of the detrimental effects of vitamin D 110 
deficiency at serum 25-hydroxy vitamin D3 concentrations of less than 50 nmol/L (less than 111 
20ng/mL). A concentration of 50 to 75 nmol/L (21 to 29 ng/mL) is considered insufficient and greater 112 
than 75nmol/L (greater than 30 ng/ml) is considered vitamin D replete. These vitamin D 113 
concentration cut-offs are those adopted by the Endocrine Society (Holick et al. 2011). Differing 114 
vitamin D concentration cut-offs have also been proposed by the Institute of Medicine (IOM), who 115 
suggest that vitamin D deficiency is when serum 25-hydroxy vitamin D3 concentrations are less than 116 
30 nmol/L (less than 12ng/mL), vitamin D insufficency is when serum 25-hydroxy vitamin D3 117 
concentrations are between 30 nmol/L and 50nmol/L (between 12 and 20ng/mL), and that serum 118 
25-hydroxy vitamin D3 concentrations greater than 50nmol/L (greater than 20ng/mL) are considered 119 
replete (Ross et al. 2011). There is agreement that serum concentrations greater than 374 nmol/L 120 
(greater than 150 ng/mL) are associated with toxicity and adverse effects (Tangpricha et al. 2002; 121 
Heaney 2008; Stephanou et al. 1994; Daftary & Taylor 2006).   122 
 123 
The biological plausibility that vitamin D plays an important role in implantation has led research 124 
groups to investigate the importance of vitamin D in patients undergoing ART. Some studies have 125 
found that replete concentrations of vitamin D lead to an increase in clinical pregnancy and live birth 126 
rates (Rudick et al. 2014; Ozkan et al. 2010; Rudick et al. 2012; Garbedian et al. 2013; Paffoni et al. 127 
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2014). However, others have found conflicting evidence suggesting that vitamin D has no effect on 128 
the outcome of ART(Anifandis et al. 2010; Aleyasin et al. 2011; Firouzabadi et al. 2014; Fabris et al. 129 
2014; Franasiak et al. 2015). The aim of our review was to investigate the association between 130 
vitamin D status and reproductive outcomes by meta-analysis of the ART outcomes of published 131 
cohort studies to summarise the available evidence. 132 
METHODS 133 
Inclusion Criteria 134 
The study was designed a priori with inclusion of primary articles that studied women undergoing 135 
any form of ART (IVF, ICSI and frozen embryo transfer [FET]) who had their vitamin D status checked. 136 
This could either be through blood serum or follicular fluid assay. The primary outcome was live 137 
birth rates according to vitamin D status. Secondary outcomes included biochemical pregnancy 138 
rates, and clinical pregnancy rates. 139 
 140 
Literature search  141 
MEDLINE, EMBASE, Cochrane Central Register of Controlled Trials and CINAHL (from inception to 142 
April 2017) were searched. The search strategy used the following key words and/or medical subject 143 
heading (MeSH) terms: pregnancy, in vitro fertilization, intracytoplasmic sperm injection, assisted 144 
reproductive techniques and vitamin D. The full electronic search strategy is provided in 145 
Supplementary Table SI. References of all included primary and review articles were examined to 146 
identify relevant articles not captured by the electronic searches. No language restrictions were 147 
applied in any of the searches or study selection. 148 
 149 
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Study selection 150 
Criteria for inclusion in the study were established prior to the literature search. Two independent 151 
reviewers (J.C. and B.T.) carried out study selection. First, the independent reviewers scrutinized the 152 
titles and abstracts of the electronic searches. Each title and abstract were included or excluded 153 
independently according to the predefined inclusion criteria; any disagreements regarding inclusion 154 
were resolved by a further reviewer (I.D.G). The full manuscripts of the titles and abstracts 155 
considered to be relevant for inclusion were obtained. When there was a duplicate publication, the 156 
most recent and complete version was selected and included. Studies that did not explicitly report 157 
results from assisted reproductive treatments according to vitamin D groups (deficient, insufficient 158 
and replete) according to Endocrine Society guidelines were excluded. 159 
 160 
The same two independent reviewers (J.C. and B.T.) extracted the outcome data from the included 161 
studies.  162 
 163 
Study quality assessment 164 
Two reviewers (J.C and B.T.) used the Newcastle-Ottawa Quality Assessment Scales for observational 165 
studies to complete a quality assessment of the included manuscripts(Wells et al. 2011). The 166 
Newcastle-Ottawa scale ranges from zero to nine, awarding one star for all categories (case-cohort 167 
representative, ascertainment of exposure, outcome negative at commencement of study, outcome 168 
assessment, duration of follow up and adequacy of follow up) except comparability by design or 169 
analysis where two stars can be awarded. An arbitrary score was allocated assuming that all items 170 
have equal weighting. This was used to give a quantitative appraisal of overall quality of the 171 
individual studies. Each study received a score from each of the reviewers. 172 
 173 
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Publication Bias 174 
Assessment for publication bias in the included studies for the outcome of clinical pregnancy was 175 
performed using Harbord’s modified test for small study effects to assess for funnel plot asymmetry 176 
((Harbord et al. 2006). 177 
Statistical analysis  178 
Live birth, biochemical pregnancy, clinical pregnancy and miscarriage rates were extracted from 179 
each of the included studies according to vitamin D strata. The log of the ratio and its corresponding 180 
standard error for each study was computed. Meta-analysis using inverse-variance weighting was 181 
performed to calculate the random-effects summary estimates. The square root of this number is 182 
the estimated standard deviation of the underlying effects across studies. Because we had relative 183 
measures of effect, the confidence intervals were centered on the natural logarithm of the pooled 184 
estimate and the limits exponentiated to obtain an interval on the ratio scale. Forest plots were 185 
created for each outcome, showing individual study proportions with confidence intervals (CIs) and 186 
the overall DerSimmonian-Laird pooled estimate according to vitamin D status. Heterogeneity of the 187 
treatment effects was assessed graphically with forest plots and statistically analyzed using the χ
2
 188 
test. Statistical analyses were performed using Stata 12.1 (StataCorp, College Station, TX). 189 
RESULTS 190 
The PRISMA flow diagram (Liberati et al. 2009; Moher et al. 2009) of the review process is presented 191 
in Fig. 1. The search strategy yielded 4615 citations, of which 4505 citations were excluded as it was 192 
clear from scrutinizing the title and abstract that they did not fulfil the selection criteria. Full 193 
manuscripts of 110 articles were obtained. A total of 99 of these publications were excluded because 194 
35 were reviews, 24 articles did not specify outcomes from ART, 17 articles did not specify 195 
investigating vitamin D, seven articles were conference abstracts or studies where there was no 196 
extractable data (Farzadi et al. 2015; Neville et al. 2016) (as they provided mean vitamin D 197 
concentrations of groups of women achieving clinical pregnancy and those that did not) , five articles 198 
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reported male infertility, four articles were animal studies, three were letters, two were duplicates, 199 
and one was a study protocol. Therefore, the total number of observational studies included in the 200 
review was 11. 201 
 202 
Study characteristics 203 
Study characteristics of the 11 included studies are presented in Table I. None of the included 204 
studies declared any conflicts of interest. The included studies varied in publication date between 205 
2010 and 2015. All 11 included studies were cohort studies; six were retrospective and five were 206 
prospective in design. Sample sizes varied between 84 women to 517 women. Nine of the 11 207 
included studies reported the ages of their study population. Seven studies had a mean age of below 208 
37 years and two had a higher mean age of 40.5 and 40.9 years. Eight included studies used serum 209 
measurement of vitamin D, two used both follicular fluid and serum vitamin D (finding that there 210 
was high correlation between the follicular fluid vitamin D and serum vitamin D in their participants), 211 
and one study used follicular fluid alone. Of the 11 included studies, nine studies reported ART 212 
where women had used autologous oocytes. Two reported results from women who were donor 213 
egg recipients. One study used pre-implantation genetic screening to ensure that patients had 214 
karyotypically normal embryos transferred. One study chose to only study women that underwent a 215 
single blastocyst transfer. All of the 11 included studies assayed 25-hydroxy-vitamin D. Four of the 216 
included studies assessed vitamin D before the commencement of the treatment cycle, three 217 
assessed vitamin D at the time of ovulation trigger, three assessed vitamin D at the time of oocyte 218 
retrieval, and one study assessed vitamin D just before oocyte retrieval. All of the 11 included 219 
studies used the Endocrine Society classification of vitamin D status (less than 50nmol/L deficient, 220 
50-75nmol/L insufficient, and greater than 75nmolL replete). Six of the included studies provided 221 
adjusted odds ratios, adjusting for potential confounding factors. Of these six studies, only four 222 
provided adequate detail for potential meta-analysis of adjusted odds ratios. However, two of these 223 
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studies had adjusted for vitamin D concentration and another two studies had used differing 224 
referent groups to obtain adjusted odds ratios. 225 
 226 
A funnel plot to test for asymmetry did not find substantial evidence of publication bias (p=0.933) 227 
(Supplementary Figure S1). 228 
 229 
All studies scored well using the Newcastle-Ottawa Quality Assessment achieving a score between 7 230 
and 9 (Table II). 231 
 232 
 233 
Vitamin D deficiency prevalence 234 
Our review found a high prevalence of vitamin D deficiency. The meta-analysed prevalence for 235 
vitamin D deficiency, insufficiency and replete were 34.6% (95% CI 32.0 to 37.4), 45.3% (95% CI 42.4 236 
to 48.5) and 25.7% (95% CI 23.4 to 28.2%) respectively. 237 
 238 
Live birth  239 
Seven studies (2026 participants) reported the live births achieved by women when categorized by 240 
vitamin D (Fig. 2). Meta-analysis of the data from these studies showed that women who are vitamin 241 
D replete have a higher chance of achieving a live birth from ART when compared with women with 242 
vitamin D deficiency or insufficiency. The odds ratio was 1.33 (1.08 to 1.65). The meta-analysis had 243 
low statistical heterogeneity with an I
2
 value of 5.0% (p=0.39).  244 
 245 
Biochemical pregnancy  246 
Five studies (1700 participants) reported the number of women that achieved a positive pregnancy 247 
test approximately two weeks after embryo transfer for the three vitamin D categories. The odds of 248 
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biochemical pregnancy in the vitamin D deficient and insufficient population versus the vitamin D 249 
replete population are presented in Fig. 3. Meta-analysis of these five cohort studies showed a 250 
greater chance of pregnancy in the vitamin D replete group when compared with the vitamin D 251 
deficient and insufficient groups with an odds ratio of 1.34 (1.04 to 1.73). There was a low level of 252 
statistical heterogeneity with an I
2
 value of 21.0% (p=0.28).  253 
 254 
Clinical pregnancy  255 
All 11 studies (2700 participants) reported on clinical pregnancy rate (the presence of fetal heart 256 
approximately five weeks after embryo transfer) as an outcome (Fig. 4). Pooling of the clinical 257 
pregnancy outcomes from the 11 studies showed an improved chance of clinical pregnancy in the 258 
vitamin D replete population when compared with the vitamin D deficient and insufficient 259 
population. The vitamin D replete group was more likely to achieve clinical pregnancy when 260 
compared with the vitamin D deficient and insufficient groups with an odds ratio of 1.46 (1.05 to 261 
2.02). The I
2
 value for this meta-analysis was 61.0% suggesting a moderate level of statistical 262 
heterogeneity (p=0.02). 263 
 264 
Data could be extracted from nine of the included studies (2082 patients) to compare the chances of 265 
clinical pregnancy by using the IOM definitions of vitamin D status (vitamin D concentrations of less 266 
than 50nmol/L considered as deficient or insufficient and vitamin D concentrations of more than 267 
50nmol/L considered replete). Pooling of the clinical pregnancy rates from these nine studies also 268 
showed that women with a vitamin D concentration of greater than 50nmol/L were more likely to 269 
achieve a clinical pregnancy when compared to women with a vitamin D concentration of below 270 
50nmol/L with an odds ratio of 1.38 (1,04 to 1.83) (Supplementary Figure S2). 271 
 272 
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Clinical pregnancy according to source of oocyte used 273 
The 11 included studies were divided into two groups according to the source of the oocyte 274 
(autologous or donor) used to form the embryo for transfer (Fig. 5). Nine studies (including 2334 275 
patients) reported fertility outcomes in infertile women receiving an autologous oocyte embryo. 276 
Clinical pregnancy was found to be more likely in women who were vitamin D replete who received 277 
an autologous oocyte embryo (OR 1.39 [1.00 to 1.93]). The I
2
 value for this meta-analysis was 56.0% 278 
suggesting a moderate level of statistical heterogeneity (p=0.02). 279 
 280 
In the two studies (including 366 patients) where women received a donor oocyte embryo, no 281 
significant difference was found when comparing the clinical pregnancy in women receiving a donor 282 
oocyte embryo who were vitamin D replete when compared to women who were vitamin D 283 
deficient or insufficient (OR 2.02 [0.44 to 9.26]). The I
2
 value for this meta-analysis was 85.0% 284 
suggesting a considerable level of statistical heterogeneity (p=0.009). 285 
 286 
Miscarriage  287 
Six studies (1635 participants) reported on the outcome of miscarriage (Fig. 6). When the data from 288 
these six studies are pooled, the chance of miscarriage in the vitamin D replete women is similar to 289 
that of vitamin D deficient and insufficient women with an odds ratio of 1.12 (0.81 to 1.54). There 290 
was a low level of statistical heterogeneity denoted by an I
2
 value of 0.0% (p=0.76).  291 
 292 
DISCUSSION 293 
This systematic review including 11 studies suggests that the chances of achieving a live birth, a 294 
positive pregnancy test and clinical pregnancy after ART are higher in women who are vitamin D 295 
replete when compared to those who are vitamin D deficient or insufficient. Miscarriage does not 296 
appear to be associated with vitamin D status. 297 
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 298 
Our analysis was strengthened by a number of factors. A comprehensive search strategy was used, 299 
employing relevant research databases. Additionally, a valid data synthesis method was 300 
implemented and no language restrictions were applied. The Newcastle-Ottawa Quality Assessment 301 
Scale was used to assess the quality of the included studies. The assessment of all studies scored 302 
well on this scale, suggesting low risk of bias. 303 
 304 
There are also weaknesses in our analysis, which mainly stem from the clinical heterogeneity of the 305 
publications that were included. Some degree of heterogeneity is to be expected due to the 306 
different geographical locations that the individual cohort studies have been conducted, leading to 307 
differing population characteristics and ART protocols used. However, this is not necessarily a 308 
disadvantage as some degree of clinical heterogeneity can increase the generalisability of the 309 
findings to wider infertility populations.  310 
 311 
Ideally, when meta-analysing cohort studies, the adjusted odds ratios (where provided) should be 312 
meta-analysed. However, in our included studies it was infrequent for the included primary studies 313 
to have provided sufficient detail of their adjusted analysis for known confounding factors such as 314 
age and BMI. Therefore, we were unable to perform a meta-analysis of adjusted odds ratios.  315 
 316 
One source of clinical heterogeneity between the included studies is in the timing of vitamin D 317 
assessment. Some of the studies measured their participants’ vitamin D status before the start of 318 
ART, whereas others measured vitamin D at the time of oocyte retrieval. Vitamin D status is known 319 
to not fluctuate over time unless vitamin D deficiency or insufficiency is actually treated (Anagnostis 320 
et al. 2013). Therefore, the importance of the difference in timing of the vitamin D assessment 321 
reduces. 322 
 323 
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There were also differences in the bio-fluid used to assess vitamin D status amongst the included 324 
studies. Three of the included studies measured vitamin D in the follicular fluid aspirated at the time 325 
of oocyte retrieval. The remaining studies used blood serum for vitamin D measurement. 326 
Reassuringly, a number of previously published studies have found that assays of vitamin D in 327 
follicular fluid or blood serum produce results that are highly correlative (Aleyasin et al. 2011; 328 
Anifandis et al. 2010; Firouzabadi et al. 2014; Ozkan et al. 2010). Serum vitamin D would be 329 
measured more conveniently in women undergoing ART and could be tested before the start of 330 
treatment to allow time for correction of deficiency.  331 
 332 
We found that the likelihood of achieving a positive pregnancy test after embryo transfer was higher 333 
in women who were replete in vitamin D. This would support the hypothesis that vitamin D affects 334 
embryo implantation. Two of the included studies have tried to investigate the effect of vitamin D on 335 
implantation further by only including women undergoing oocyte recipient treatment cycles (Fabris 336 
et al. 2014; Rudick et al. 2014). Isolating recipients of donor oocyte embryos aims to reduce the 337 
impact of oocyte quality on reproductive outcomes. Donated oocytes would be sourced from 338 
younger women with higher quality oocytes and therefore implantation can be investigated more 339 
accurately. Meta-analysis of the clinical pregnancy data from these two studies (including 366 340 
patients) did not show a statistically significant difference in chance of clinical pregnancy between 341 
the vitamin D replete and vitamin D deficient or insufficient populations. However, the data 342 
maydoes suggest show a trend towards a higher chance of clinical pregnancy in the vitamin D 343 
replete group. It is likely that the failure to reach statistical significance is due to the low number of 344 
participants in view of the wide confidence intervals (Schünemann et al. 2011). Removal of these 345 
two studies from the overall analysis did not alter the overall association between vitamin D 346 
concentration and clinical pregnancy.  347 
 348 
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Seasonal variations in conception rates have been established (Rojansky et al. 1992) with higher 349 
conception rates found in the Summer and Autumn. Although many hypotheses have been 350 
postulated to explain this phenomenon (e.g. reduced ovulation rates and poorer sperm quality in 351 
darker months) the exact mechanism behind this has not been explained. It is possible that an 352 
increase in sun exposure and greater sunlight luminosity increases the body’s store of vitamin D, 353 
thereby yielding higher conception rates in Summer and Autumn. 354 
 355 
Although the debate regarding the importance of vitamin D and seasonal variation in reproductive 356 
health continues, its impact on immunomodulation within the endometrium with a resultant 357 
reduction in active inflammatory cytokines is now well understood (Holick 2007). The expression of 358 
vitamin D receptors at the level of the endometrium and the role of vitamin D in the transcription of 359 
HOX10A gene (found to be of key importance in implantation) suggest that the immunomodulatory 360 
effects of vitamin D may have a direct impact on implantation and therefore the likelihood of 361 
reproductive treatment success (Evans et al. 2004). 362 
 363 
Ethnicity has also been found to be a prognostic marker for IVF treatment success, with women of 364 
Asian and Black ethnic origins having worse reproductive outcomes (Dhillon et al. 2016). One 365 
possible explanation for this finding could be lower serum vitamin D concentrations in these ethnic 366 
groups or differences in the vitamin D receptor gene polymorphisms (Ingles 2007; John et al. 2007).  367 
 368 
Our review demonstrates that replete vitamin D status is associated with greater chances of ART 369 
success. This could be via the actions of vitamin D on the endometrium promoting embryo 370 
implantation or as a surrogate marker for general well-being (Lerchbaum & Rabe 2014). Vitamin D 371 
serum testing is relatively cheap and widely available and its treatment is not costly. Therefore it 372 
may be beneficial to diagnose and treat vitamin D deficiency in women planning ART to optimize 373 
their pregnancy outcomes. Correction of vitamin D deficiency in these patients would also be of 374 
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benefit during pregnancy, as replete vitamin D concentrations have been found to reduce the risk of 375 
obstetric complications such as gestational diabetes (Wang et al. 2012; Zhang et al. 2015), pre-376 
eclampsia (Moon et al. 2015; De-Regil et al. 2012; Wei 2014), and fetal growth restriction (Conde-377 
Agudelo et al. 2013; Khalessi et al. 2015). To further investigate the value of treatment of vitamin D 378 
deficiency in the infertile population an interventional trial would be necessary. 379 
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Figure Legends 542 
Figure 1. PRISMA flow diagram for study selection. 543 
 544 
Figure 2. Meta-analysis of studies reporting live birth by vitamin D concentrations. Meta-analysis of 545 
the data from seven included studies that reported live birth as an outcome showed that women 546 
who are vitamin D replete have a higher chance of achieving a live birth from ART when compared 547 
with women with vitamin D deficiency or insufficiency. F-H, Fixed; Fixed effects (Mantel-Haenszel)  548 
 549 
Figure 3. Meta-analysis of studies reporting biochemical pregnancy by vitamin D concentrations. 550 
Meta-analysis of the data from five included studies that reported biochemical pregnancy as an 551 
outcome showed that women who are vitamin D replete have a higher chance of achieving a 552 
positive pregnancy test from ART when compared with women with vitamin D deficiency or 553 
insufficiency. 554 
 555 
Figure 4. Meta-analysis of studies reporting clinical pregnancy by vitamin D concentrations. Meta-556 
analysis of the data from all 11 of the included studies that reported clinical pregnancy as an 557 
outcome showed that women who are vitamin D replete have a higher chance of achieving clinical 558 
pregnancy from ART when compared with women with vitamin D deficiency or insufficiency. 559 
 560 
Figure 5. Meta-analysis of studies reporting clinical pregnancy by vitamin D concentrations according 561 
to source of oocyte. Meta-analysis of the data from nine included studies showed that women who 562 
are vitamin D replete have a higher chance of achieving a clinical pregnancy from ART using 563 
autologous oocytes when compared with women with vitamin D deficiency or insufficiency. Meta-564 
analysis of the data from two included studies showed no difference in the chance of clinical 565 
pregnancy in women replete, insufficient or deficient in vitamin D undergoing ART using donor 566 
oocytes. 567 
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 568 
Figure 6. Meta-analysis of studies reporting miscarriage by vitamin D concentrations. Meta-analysis 569 
of the data from six included studies that reported miscarriage as an outcome showed no difference 570 
in the chance of miscarriage in women replete, insufficient or deficient in vitamin D undergoing ART. 571 
 572 
Supplementary Figure S1. Vitamin D and in vitro fertilisation treatment clinical pregnancy outcomes 573 
publication bias funnel plot. The funnel plot to test for asymmetry showed no substantial evidence 574 
of publication bias. 575 
 576 
Supplementary Figure S2. Meta-analysis of studies reporting clinical pregnancy by vitamin D 577 
concentrations implementing Institute of Medicine cut-offs. Data could be extracted from nine of 578 
the included studies to compare the chances of clinical pregnancy by using the Institute of Medicine 579 
definitions of vitamin D status (vitamin D concentrations of less than 50nmol/L considered as 580 
deficient or insufficient and vitamin D concentrations of more than 50nmol/L considered replete). 581 
Meta-analysis of the data from these nine studies showed that women who are vitamin D replete 582 
have a higher chance of achieving clinical pregnancy from ART when compared with women with 583 
vitamin D deficiency or insufficiency according to Institute of Medicine vitamin D cut-offs. 584 
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main text. 
Comment [RC12]: Please give a brief 
description interpreting the plot, so the figure 
stands alone without needing to refer back to the 
main text. 
Comment [RC13]: Please give a brief 
description interpreting the plot, so the figure 
stands alone without needing to refer back to the 
main text. 
Page 49 of 65
http://humrep.oupjournals.org
Draft Manuscript Submitted to Human Reproduction for Peer Review
Total number of citations retrieved from electronic 
searches; n=4615 
Citations excluded after screening title and abstract; n= 4505 
Full manuscripts retrieved for detailed assessment; n= 110 
Articles excluded after review of full manuscripts and reasons for 
exclusion; n= 99 
Reviews   n=35 
Not specific to assisted reproductive techniques  n=24 
Not specific to vitamin D  n=17 
Conference abstract, no data to abstract n=7 
Male infertility   n=5 
Animal studies   n=4 
Letter   n=3 
Duplicates   n=3 
Study protocol   n=1 
 
 
Articles included for systematic review; n= 11  
Figure 1. PRISMA flow diagram for study selection.  
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Figure 2. Meta-analysis of studies reporting live birth by vitamin D concentrations  
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Figure 5. Meta-analysis of studies reporting clinical pregnancy by vitamin D 
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Author (year) Study 
design 
 
Study 
population 
 
Age of study 
population 
Bio-fluid used 
for vitamin D 
assessment 
Timing of 
vitamin D 
assessment 
Method of 
vitamin D 
assessment 
Vitamin 
D cut-
offs 
utilised 
Autologous 
or donated  
oocyte 
Summary of results Confounders  
adjustment 
Conclusions 
Anifandis et al., 
(2010) 
Prospective 
Cohort 
101 women 
undergoing IVF 
in Greece 
Not reported Vitamin D in 
follicular fluid 
At oocyte 
retrieval 
25-OH vitamin D  
by 
electrochemilumi
nescence 
immunoassay  
(ECLIA) 
 
Deficien
cy 
<50nmo
l/L 
 
Insuffici
ency 
50-
75nmol/
L 
 
Replete 
>75nmo
l/L 
Autologous 
 
Clinical pregnancy 
(intrauterine sac seen 
3-4 weeks on 
ultrasound scan post-
HCG) 
10/31 deficient group 
16/49 insufficient 
group 
3/21 replete group 
 
Pregnancy test positive 
Data not provided 
 
Miscarriage 
Data not provided 
 
 
 
Live birth 
Data not provided 
 
Nil Follicular fluid vitamin 
D concentrations 
significantly correlated 
to the quality of the 
embryos.  Data 
suggested that high 
concentrations of 
vitamin D led to a 
decreased chance of 
clinical pregnancy 
 
 Fabris et al., 
(2014) 
Retrospective 
Cohort 
267 women 
undergoing 
donor oocyte 
IVF in Spain 
Mean age 40.5 
years 
Vitamin D in 
serum 
At oocyte 
retrieval 
25-OH vitamin D 
by enzyme-linked 
immunosorbent 
assay (ELISA) 
 
Deficien
cy 
<50nmo
l/L 
 
Insuffici
ency 
50-
75nmol/
L 
 
Replete 
>75nmo
l/L 
 Donated 
 
Clinical pregnancy 
(intrauterine sac seen 5 
weeks on ultrasound 
scan after embryo 
transfer) 
68/92 deficient group 
94/134 insufficient 
group 
29/41 replete group 
 
Pregnancy test positive 
(pregnancy test 
positive 2 weeks after 
embryo transfer) 
60/92 deficient group 
85/134 insufficient 
group 
25/41 replete group 
 
Miscarriage 
(pregnancy loss after 
clinical pregnancy 
achieved) 
8/92 deficient group 
9/134 insufficient group 
4/41 replete group 
 
Live birth 
56/92 deficient group 
71/134 insufficient group 
23/41 replete group 
Nil No significant 
difference in 
implantation or clinical 
pregnancy rates 
between deficient, 
insufficient and replete 
vitamin D groups 
 
Firouzabadi et 
al., (2014) 
Prospective 
Cohort 
221 women 
undergoing IVF 
in Iran 
Mean age 29.2 
years 
 
 
Vitamin D in 
follicular fluid 
and serum 
At oocyte 
retrieval 
25-OH vitamin D 
by enzyme-linked 
immunosorbent 
assay (ELISA) 
 
Deficien
cy 
<25nmo
l/L 
 
Insuffici
ency 
25-
75nmol/
L 
 
Replete 
>75nmo
l/L 
Autologous 
 
Clinical pregnancy 
(intrauterine sac seen 
on ultrasound scan [no 
time point defined]) 
23/50 deficient group 
47/155 insufficient 
group 
4/16 replete group 
 
Pregnancy test positive 
Data not provided 
 
Miscarriage 
Data not provided 
 
 
 
Live birth 
Data not provided 
 
Nil No significant 
correlation between 
follicular fluid or serum 
vitamin D and clinical 
pregnancy rate.  
Significant correlation 
between follicular fluid 
vitamin D 
concentrations and 
serum vitamin D 
concentrations  
 
Table I. Characteristics of included studies  
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Franasiak et al., 
(2015) 
Retrospective 
cohort 
517 women 
undergoing IVF 
with euploid 
blastocyst 
transfer in USA 
Mean age 35.0 
years 
Vitamin D in 
serum 
At ovulation 
trigger 
injection 
25-OH vitamin D 
by enzyme-linked 
immunosorbent 
assay (ELISA) 
 
Deficien
cy 
<50nmo
l/L 
 
Insuffici
ency 
50-
75nmol/
L 
 
Replete 
>75nmo
l/L 
Autologous 
 
Clinical pregnancy 
(intrauterine sac seen 
on ultrasound scan [no 
time point 
defined])144/206 
deficient group 
151/215 insufficient 
group 
64/96 replete group 
 
Pregnancy test positive 
(pregnancy test 
positive 2 weeks after 
embryo 
transfer)163/206 
deficient group 
162/215 insufficient 
group 
74/96 replete group 
 
Miscarriage 
(pregnancy loss after 
positive pregnancy test 
but before intrauterine 
gestational sac seen or 
pregnancy loss after 
gestational sac seen) 
32/206 deficient group 
29/215 insufficient group 
14/96 replete group 
 
Live birth 
131/206 deficient group 
133/215 insufficient 
group 
60/96 replete group 
Adjustment for age, BMI, 
ethnicity, season, number of 
previous treatment cycles, 
number of embryos transferred 
Vitamin D status 
unrelated to pregnancy 
rates in women 
undergoing euploid 
blastocyst transfers 
 
Fru et al., 
(2014) 
Retrospective 
Cohort 
102 women 
undergoing IVF 
in USA 
Not reported 
 
Vitamin D in 
serum 
Pre-cycle but 
not defined 
25-OH vitamin D 
Method not 
defined 
Deficien
cy 
<50nmo
l/L 
 
Insuffici
ency 
50-
75nmol/
L 
 
Replete 
>75nmo
l/L 
Autologous 
 
Clinical pregnancy 
(not defined) 
6/18 deficient group 
24/47 insufficient 
group 
37/58 replete group 
 
Pregnancy test positive 
Data not provided 
 
Miscarriage 
(not defined) 
1/6 deficient group 
9/24 insufficient group 
12/37 replete group 
 
Live birth 
5/18 deficient group 
15/47 insufficient group 
25/58 replete group 
Nil Higher vitamin D 
concentrations 
correlated with 
increased likelihood of 
positive pregnancy 
test.  Overall live birth 
rates highest in vitamin 
D replete group.  
 
Garbedian et 
al., (2013) 
Prospective 
Cohort  
173 women 
undergoing IVF 
in Canada 
Mean age 34.5 
years  
Vitamin D in 
serum 
Before 
oocyte 
retrieval 
25-OH vitamin D 
Method not 
defined 
Deficien
cy and 
insuffici
ency 
<75nmo
l/L 
 
Replete 
>75nmo
l/L 
Autologous 
 
Clinical pregnancy 
(intrauterine sac seen 
on ultrasound scan [no 
time point defined]) 
33/95 deficient and 
insufficient groups 
combined 
41/78 replete group 
 
Pregnancy test positive 
Data not provided 
 
Miscarriage 
Data not provided 
 
 
 
 
Live birth 
Data not provided 
 
Adjustment for age, BMI,  
number of embryos transferred 
and vitamin D concentration 
Implantation and 
clinical pregnancy rates 
are higher in the 
vitamin D sufficient 
group (>75nmol/L).  
Statistical significant 
difference in clinical 
pregnancy rate, no 
statistical difference in 
pregnancy positive 
rate.   
 
Ozkan et al., 
(2010) 
 
Prospective 
Cohort 
84 women 
undergoing IVF 
in Turkey 
Mean age 34.4 
years 
Vitamin D in 
follicular fluid 
and serum 
At ovulation 
trigger 
injection 
25-OH vitamin D 
Method not 
defined 
Deficien
cy 
<50nmo
l/L 
 
Insuffici
Autologous 
 
Clinical pregnancy 
(intrauterine sac seen 
on ultrasound scan [no 
time point defined]) 
5/23 deficient group 
6/30 insufficient group 
Miscarriage 
Data not provided 
 
 
 
Live birth 
Adjustment for age, BMI, 
ethnicity, number of embryos 
transferred and vitamin D 
concentration 
Serum and follicular 
fluid strong correlated.  
Higher implantation 
and clinical pregnancy 
rates in insufficient 
(20-30ng/ml) and 
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ency 
50-
75nmol/
L 
 
Replete 
>75nmo
l/L 
15/31 replete group 
 
Pregnancy test positive 
(pregnancy test 
positive 2 weeks after 
embryo transfer) 
3/23 deficient group 
4/30 insufficient group 
8/31 replete group 
Data not provided 
 
replete concentrations 
(>30ng/ml) when 
compared to deficient 
group - highest in 
replete group. 
 
Paffoni et 
al.,(2014) 
Prospective 
cohort 
335 women 
undergoing IVF 
in Italy 
Mean age 36.9 
years 
Vitamin D in 
serum 
Pre-cycle but 
not defined 
25-OH vitamin D 
by 
electrochemilumi
nescence 
immunoassay  
(ECLIA) 
 
Deficien
cy 
<50nmo
l/L 
 
Insuffici
ency 
50-
75nmol/
L 
 
Replete 
>75nmo
l/L 
 
 
Autologous 
 
Clinical pregnancy 
(intrauterine sac seen 
on ultrasound scan [no 
time point defined]) 
30/154 deficient group 
33/117 insufficient 
group 
23/64 replete group 
 
Pregnancy test positive 
(pregnancy test 
positive 2 weeks after 
embryo transfer) 
34/154 deficient group 
36/117 insufficient 
group 
25/64 replete group 
 
Miscarriage 
Data not provided 
 
 
 
Live birth 
29/154 deficient group 
28/117 insufficient group 
19/64 replete group 
Nil Analysis suggested 
those with a vitamin D 
>75nmol/L had the 
highest chance of 
clinical pregnancy 
when compared with 
those with vitamin D 
deficiency or 
insufficiency.  
 
Polyzos et al., 
(2014) 
Retrospective 
cohort 
368 women 
undergoing IVF 
resulting in 
single 
blastocyst 
embryo 
transfer in 
Belgium 
Mean age 30.6 
years 
 
 
Vitamin D in 
serum 
At ovulation 
trigger 
injection 
25-OH vitamin D 
by enzyme-linked 
immunosorbent 
assay (ELISA) 
 
Deficien
cy 
<50nmo
l/L 
 
Insuffici
ency 
50-
75nmol/
L 
 
Replete 
>75nmo
l/L 
 
Autologous 
 
Clinical pregnancy 
(intrauterine sac seen 5 
weeks on ultrasound 
scan after embryo 
transfer) 
98/239 deficient group 
70/129  insufficient 
and replete group 
combined 
 
Pregnancy test positive 
(pregnancy test 
positive 2 weeks after 
embryo transfer) 
124/239 deficient 
group 
86/129 insufficient and 
replete groups 
combined 
 
Miscarriage 
(pregnancy loss after 
positive pregnancy test 
but before intrauterine 
gestational sac seen or 
pregnancy loss after 
gestational sac seen) 
44/239 deficient group 
25/129 insufficient and 
replete groups combined 
 
Live birth 
78/239 deficient group 
61/129 insufficient and 
replete groups combined 
Adjustment for age, number of 
previous treatment cycles, type 
of treatment protocol. Type of 
gonadotrophin used, starting 
dose of gonadotrophin, E2 levels 
on day of HCG, number of 
oocytes collected, type of 
treatment, day 5 embryo 
transfer, top quality embryo 
transfer, endometrial thickness, 
serum progesterone at trigger 
injection, season and vitamin D 
concentration 
Clinical pregnancy rate 
significantly lower in 
vitamin D deficient 
group p=0.015.  
Controlled for 16 
confounding factors.   
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Rudick et al., 
(2012) 
Retrospective 
cohort 
188 women 
undergoing IVF 
in USA  
Mean age 36.0 
years 
 
Vitamin D in 
serum 
Pre-cycle but 
not defined 
25-OH vitamin D 
by enzyme-linked 
immunosorbent 
assay (ELISA) 
 
Deficien
cy 
<50nmo
l/L 
 
Insuffici
ency 
50-
75nmol/
L 
 
Replete 
>75nmo
l/L 
 
Autologous 
 
Clinical pregnancy 
(intrauterine sac seen 5 
weeks on ultrasound 
scan after embryo 
transfer) 
14/39 deficient group 
29/70 insufficient 
group 
34/79 replete group 
 
Pregnancy test positive 
Data not provided 
 
Miscarriage 
(pregnancy loss after 
positive pregnancy test 
but before intrauterine 
gestational sac seen or 
pregnancy loss after 
gestational sac seen) 
3/39 deficient group 
7/70 insufficient group 
8/79 replete group 
 
Live birth 
11/39 deficient group 
22/70 insufficient group 
26/79 replete group 
Adjustment for age, number of 
embryos transferred, embryo 
quality, and diagnosis of 
diminished ovarian reserve 
Vitamin D deficiency 
associated with lower 
CPR in non-hispanic 
whites but not in 
Asians 
 
Rudick et al., 
(2014) 
Retrospective 
cohort 
99 women 
undergoing 
donor oocyte 
IVF in USA 
Mean age 40.9 
years 
 
Range 21-39  
Vitamin D in 
serum  
Pre-cycle but 
not defined 
25-OH vitamin D 
by enzyme-linked 
immunosorbent 
assay (ELISA) 
 
Deficien
cy 
<50nmo
l/L 
 
Insuffici
ency 
50-
75nmol/
L 
 
Replete 
>75nmo
l/L 
Donated 
 
Clinical pregnancy 
(intrauterine sac seen 5 
weeks on ultrasound 
scan after embryo 
transfer) 
9/26 deficient group 
16/38 insufficient 
group 
26/35 replete group 
 
Pregnancy test positive 
Data not provided 
 
Miscarriage 
(pregnancy loss after 
positive pregnancy test 
but before intrauterine 
gestational sac seen or 
pregnancy loss after 
gestational sac seen) 
1/26 deficient group 
3/38 insufficient group 
6/35 replete group 
 
Live birth 
8/26 deficient group 
13/38 insufficient group 
20/35 replete group 
Adjustment for embryo quality, 
BMI and ethnicity 
Lower CPRs in those 
with vitamin D 
deficiency suggesting 
that the effects are 
localised within the 
endometrium 
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 Table II. Newcastle-Ottawa Scale appraisal of included studies 
 
Study Case 
representative 
Control 
representative 
Ascertainment 
of exposure 
Outcome 
negative at 
start 
Comparability by 
design or analysis 
Outcome 
assessment 
Duration 
of follow 
up 
Adequacy of 
follow up 
Score 
 
Anifandis et al., (2010) 
* * * * ** * * x 8 
 
Fabris et al., (2014) 
* * * * * * * * 8 
Firouzabadi et al.,  
(2014) 
 
* * * * x * * * 7 
 
Franasiak et al., (2015) 
* * * * * * * * 8 
 
Fru et al., (2014) 
* * * * x * * * 7 
 
Garbedian et al., (2013) 
* * * * * * * * 8 
 
Ozkan et al., (2010) 
* * * * ** * * * 9 
 
Paffoni et al., (2014) 
* * * * * * * * 8 
 
Polyzos et al., (2014) 
* * * * ** * * * 9 
 
Rudick et al., (2012)  
* * * * x * * * 7 
 
Rudick et al., (2014) 
* * * * ** * * * 9 
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Supplementary Figure S1. Vitamin D and in vitro fertilisation 
treatment clinical pregnancy outcomes publication bias funnel plot 
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Study 
Anifanidis 2010 
Fabris 2014 
Franasiak 2014 
Fru 2014 
Ozkan 2008 
Paffoni 2014 
Polyzos 2014 
Rudick 2012 
Rudick 2014 
Total (95% CI) 
Total events 
Heterogeneity: Tau² = 0.07; Chi² = 13.64, df = 8 (P = 0.09); I² = 41% 
Test for overall effect: Z = 2.23 (P = 0.03) 
Events 
19 
123 
215 
61 
21 
56 
70 
63 
42 
670 
Total 
70 
175 
311 
105 
61 
181 
129 
149 
73 
1254 
Events 
10 
68 
144 
6 
5 
30 
98 
14 
9 
384 
Total 
31 
92 
206 
18 
23 
154 
239 
39 
26 
828 
Weight 
7.1% 
13.4% 
19.1% 
5.8% 
5.2% 
15.1% 
17.4% 
9.9% 
7.0% 
100.0% 
M-H, Random, 95% CI 
0.78 [0.31, 1.96] 
0.83 [0.47, 1.47] 
0.96 [0.66, 1.41] 
2.77 [0.97, 7.95] 
1.89 [0.61, 5.81] 
1.85 [1.11, 3.08] 
1.71 [1.11, 2.63] 
1.31 [0.63, 2.72] 
2.56 [1.01, 6.50] 
1.38 [1.04, 1.83] 
Vit D replete 
Vit D Insufficiency/ 
deficient Odds Ratio Odds Ratio 
M-H, Random, 95% CI 
0.1 0.2 0.5 2 5 10 
Favours replete 
Supplementary Figure S2. Meta-analysis of studies reporting clinical pregnancy by vitamin D 
concentrations implementing Institute of Medicine cut-offs 
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Supplementary Table S1 
 
Full electronic search strategy: Vitamin D and Assisted Reproductive 
Treatment Outcomes 
 
 
 
Line 
 
 
Database 
 
Search term 
1 Medline “pregnancy”.ti,ab 
2 Medline “in vitro fertilisation”.ti,ab 
3 Medline “intracytoplasmic sperm injection”.ti,ab 
4 Medline “assisted reproductive treatment”.ti,ab 
5 Medline 1 OR 2 OR 3 OR 4 
6 Medline VITAMIN D/ 
7 Medline ((vitamin ADJ D)).ti,ab 
8 Medline ((cholecalciferol OR ergocalciferol)).ti,ab 
9 Medline 6 OR 7 OR 8 
10 Medline 5 AND 9 
 
ti; title, ab; abstract, ADJ; adjacent 
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PRISMA 2009 Checklist 
Section/topic  # Checklist item  
Reported on 
page #  
TITLE   
Title  1 Identify the report as a systematic review, meta-analysis, or both.  Page 1 
ABSTRACT   
Structured summary  2 Provide a structured summary including, as applicable: background; objectives; data sources; study eligibility 
criteria, participants, and interventions; study appraisal and synthesis methods; results; limitations; conclusions 
and implications of key findings; systematic review registration number.  
Page 3 to 4 
INTRODUCTION   
Rationale  3 Describe the rationale for the review in the context of what is already known.  Page 5 to 7 
Objectives  4 Provide an explicit statement of questions being addressed with reference to participants, interventions, 
comparisons, outcomes, and study design (PICOS).  
Page 7 
METHODS   
Protocol and registration  5 Indicate if a review protocol exists, if and where it can be accessed (e.g., Web address), and, if available, 
provide registration information including registration number.  
Not registered 
Eligibility criteria  6 Specify study characteristics (e.g., PICOS, length of follow-up) and report characteristics (e.g., years 
considered, language, publication status) used as criteria for eligibility, giving rationale.  
Page 7 
Information sources  7 Describe all information sources (e.g., databases with dates of coverage, contact with study authors to identify 
additional studies) in the search and date last searched.  
Page 7 
Search  8 Present full electronic search strategy for at least one database, including any limits used, such that it could be 
repeated.  
Supplementary 
File S1 
Study selection  9 State the process for selecting studies (i.e., screening, eligibility, included in systematic review, and, if 
applicable, included in the meta-analysis).  
Page 8 
Data collection process  10 Describe method of data extraction from reports (e.g., piloted forms, independently, in duplicate) and any 
processes for obtaining and confirming data from investigators.  
Page 8 
Data items  11 List and define all variables for which data were sought (e.g., PICOS, funding sources) and any assumptions 
and simplifications made.  
Page 7 
Risk of bias in individual 
studies  
12 Describe methods used for assessing risk of bias of individual studies (including specification of whether this 
was done at the study or outcome level), and how this information is to be used in any data synthesis.  
Page 8 to 9 
Summary measures  13 State the principal summary measures (e.g., risk ratio, difference in means).  Page 7 to 9 
Synthesis of results  14 Describe the methods of handling data and combining results of studies, if done, including measures of 
consistency (e.g., I
2
) for each meta-analysis.  
Page 9 
 
Page 64 of 65
http://humrep.oupjournals.org
Draft Manuscript Submitted to Human Reproduction for Peer Review
PRISMA 2009 Checklist 
Page 1 of 2  
Section/topic  # Checklist item  
Reported on 
page #  
Risk of bias across studies  15 Specify any assessment of risk of bias that may affect the cumulative evidence (e.g., publication bias, selective 
reporting within studies).  
Page 9 and 
supplementary 
file S2 
Additional analyses  16 Describe methods of additional analyses (e.g., sensitivity or subgroup analyses, meta-regression), if done, 
indicating which were pre-specified.  
Page 7 to 9 
RESULTS   
Study selection  17 Give numbers of studies screened, assessed for eligibility, and included in the review, with reasons for 
exclusions at each stage, ideally with a flow diagram.  
Page 9 and 
figure 1 
Study characteristics  18 For each study, present characteristics for which data were extracted (e.g., study size, PICOS, follow-up period) 
and provide the citations.  
Page 10 and 
table 1 
Risk of bias within studies  19 Present data on risk of bias of each study and, if available, any outcome level assessment (see item 12).  Page 11, 
supplementary 
file S2 and 
table 1 
Results of individual studies  20 For all outcomes considered (benefits or harms), present, for each study: (a) simple summary data for each 
intervention group (b) effect estimates and confidence intervals, ideally with a forest plot.  
Page 11 to 13, 
Figures 2 to 6 
and Table 1 
Synthesis of results  21 Present results of each meta-analysis done, including confidence intervals and measures of consistency.  Page 11 to 13 
and Figures 2 
to 6 
Risk of bias across studies  22 Present results of any assessment of risk of bias across studies (see Item 15).  Page 11 and 
supplementary 
file S2 
Additional analysis  23 Give results of additional analyses, if done (e.g., sensitivity or subgroup analyses, meta-regression [see Item 
16]).  
Page 12 to 13, 
Figure 5 and 
supplementary 
file S3 
DISCUSSION   
Summary of evidence  24 Summarize the main findings including the strength of evidence for each main outcome; consider their 
relevance to key groups (e.g., healthcare providers, users, and policy makers).  
Page 13-14 
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PRISMA 2009 Checklist 
Limitations  25 Discuss limitations at study and outcome level (e.g., risk of bias), and at review-level (e.g., incomplete retrieval 
of identified research, reporting bias).  
Page 14 
Conclusions  26 Provide a general interpretation of the results in the context of other evidence, and implications for future 
research.  
Page 14 to 17 
FUNDING   
Funding  27 Describe sources of funding for the systematic review and other support (e.g., supply of data); role of funders for 
the systematic review.  
Page 18 
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